Regnum Corp
Regnum Corp. develops and commercializes therapeutics that treat rare and infectious diseases. It develops Leronlimab (PRO 140), a monoclonal antibody C"C chemokine receptor type 5 antagonist, that is designed to prevent human immunodeficiency virus from entering human cells. The company was incorporated in 2016 and is based in New York, New York.
Market Cap & Net Worth: Regnum Corp (RGMP)
Regnum Corp (PINK:RGMP) has a market capitalization of $2.29K ($2.29K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50548 globally and #15459 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Regnum Corp's stock price $0.00 by its total outstanding shares 22950000 (22.95 Million).
Regnum Corp Market Cap History: 2019 to 2025
Regnum Corp's market capitalization history from 2019 to 2025. Data shows change from $1.95 Million to $2.29K (-71.32% CAGR).
Regnum Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Regnum Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
385.56x
Regnum Corp's market cap is 385.56 times its annual revenue
0.76x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.95 Million | $6.30K | -$36.38K | 309.64x | N/A |
| 2020 | $5.74 Million | $9.00K | -$117.67K | 637.50x | N/A |
| 2021 | $3.47 Million | $9.00K | -$270.00K | 385.56x | N/A |
Competitor Companies of RGMP by Market Capitalization
Companies near Regnum Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Regnum Corp by market ranking:
- Netflix Inc (NASDAQ:NFLX): Ranked #28 globally with a market cap of $399.17 Billion USD.
- Walt Disney Company (NYSE:DIS): Ranked #96 globally with a market cap of $174.52 Billion USD.
- The Walt Disney Company (F:WDP): Ranked #106 globally with a market cap of $158.63 Billion USD ( €154.54 Billion EUR).
- Warner Bros Discovery Inc (NASDAQ:WBD): Ranked #339 globally with a market cap of $64.45 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #28 | Netflix Inc | NASDAQ:NFLX | $399.17 Billion | $95.20 |
| #96 | Walt Disney Company | NYSE:DIS | $174.52 Billion | $98.66 |
| #106 | The Walt Disney Company | F:WDP | $158.63 Billion | €86.69 |
| #339 | Warner Bros Discovery Inc | NASDAQ:WBD | $64.45 Billion | $27.51 |
Regnum Corp Historical Marketcap From 2019 to 2025
Between 2019 and today, Regnum Corp's market cap moved from $1.95 Million to $ 2.29K, with a yearly change of -71.32%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $2.29K | 0.00% |
| 2024 | $2.29K | -98.31% |
| 2023 | $135.41K | -95.63% |
| 2022 | $3.10 Million | -10.71% |
| 2021 | $3.47 Million | -39.52% |
| 2020 | $5.74 Million | +194.12% |
| 2019 | $1.95 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Regnum Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.29K USD |
| MoneyControl | $2.29K USD |
| MarketWatch | $2.29K USD |
| marketcap.company | $2.29K USD |
| Reuters | $2.29K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.